chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced body aches. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
"I threw up and am not feeling good."  She bagan gasping for air.  Was administered epinephrine 1:1000 (1mg/cc), 0.5cc given in arm. Taken directly to ER, as she was all ready at the hospital.
site of injection changed to pink; site of injection color was red; vaccine had a tan color.; fever; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (site of injection changed to pink), VACCINATION SITE ERYTHEMA (site of injection color was red), PRODUCT COLOUR ISSUE (vaccine had a tan color.), PYREXIA (fever) and NAUSEA (nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE DISCOLOURATION (site of injection changed to pink), VACCINATION SITE ERYTHEMA (site of injection color was red), PRODUCT COLOUR ISSUE (vaccine had a tan color.), PYREXIA (fever) and NAUSEA (nausea). On 12-Feb-2021, PRODUCT COLOUR ISSUE (vaccine had a tan color.) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (site of injection changed to pink), VACCINATION SITE ERYTHEMA (site of injection color was red), PYREXIA (fever) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Body temperature: 101.3-101.5 (High) 101.3-101.5 F.         Treatment medication not provided. Concomitant medication not provided   This case was linked to MOD-2021-032836 (E2B Linked Report).; Sender's Comments:  MOD-2021-032836:1st dose case
Tachycardia for 24 hours after administration of vaccines. Patient went to  ER following day.
large bruise at injection site for approximately 2 weeks and not resolving, consistent fever and swelling at injection site
This shot was a bolster for the Pfizer shots given on 2/1/2021 and 2/22/2021.  The 3rd shot came after a three day hospitalization for a minor case of Covid-19 on September 3 to 5, 2021.  My case of Covid-19 was like a mild cold.  No major issues.    The effects of the 3rd shot started the night of the shot 9/21/2021 at approximately 1030 PM.  The next day, 9/22/2021, stayed in bed all day and was very tired., had no desire to eat.  Drank fluid all day.  The nest 9/23/2021, all symptoms had vacated and every thing returned to normal.
Severe soreness from the waist down, feeling like body aches as a flu symptom. Exhaustion. Felt plain crappy.  Left work early (20 hours after vaccination) and slept most of the afternoon and night. Feel pretty much back to ?normal? this morning (42 hours after vaccination) No medication taken or doctor visit. Just rest.
She has UTI; This is a spontaneous report from a Pfizer Sponsored Program. A Non contactable consumer reported for a female patient (mother).  A female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection: Lot number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient discovered that she has Urinary tract infection (UTI). The patient stated that She was currently taking antibiotics as treatment medication for the event. The patient wanted to know if it was okay to get her second dose scheduled tomorrow. The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient got the flu shot in the morning and went home. She called the pharmacy in the afternoon (about couple of hours later) and reported HIVES on back, arm, and scalp. She also added later itch and light headache. Symptoms were relieved by OTC BENADRYL.
pt couldn't walk at all; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): LRN4901136.  A 62-year-old female patient received BNT162b2 (BNT162B2 NOS), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Clumsy" (unspecified if ongoing); "Double vision" (unspecified if ongoing); "Limp" (unspecified if ongoing); "Trouble walkig" (unspecified if ongoing); "COVID" (unspecified if ongoing). Concomitant medication(s) included: OCREVUS; RITUXAN. Vaccination history included: Bnt162b2 (DOSE NUMBER UNKNOWN, SINGLE; Lot number: unknown), for COVID-19 Immunization. The following information was reported: GAIT INABILITY (medically significant), outcome "unknown", described as "pt couldn't walk at all".  Clinical course: On unknown date, patient started therapy with Pfizer COVID vaccine for unknown indication. On unknown date, it was reported that patient experienced: got COVID, waited a month, got her second Pfizer and then patient had a very bad reaction to it where patient couldn't walk at all.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  BNT162B2 is under agreement with Agency.
Myocarditis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 29-year-old male patient received BNT162b2 (COMIRNATY), on 09Dec2021 as dose 3 (booster), 0.3 ml single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1), administration date: 01May2021, for COVID-19 immunization, reaction(s): "thinks that an incorrect dose may have been administered to him on his first shot"; BNT162b2 (DOSE 2), administration date: 22May2021, for COVID-19 immunization. The following information was reported: MYOCARDITIS (medically significant), outcome "unknown".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200996852 same reporter/patient, different dose and event.;
Reported that within 2 minutes of receiving vaccine,began to experience a swelling feeling in his throat.
NUMBNESS IN RIGHT HAND AND FINGERTIPS; TINGLING IN RIGHT ARM AND FINGERTIPS; TINGLING IN LEFT ARM AND FINGERS; DRY MOUTH; COULD NOT EAT MUCH; FELT LIKE A TRUCK HIT; INJECTION SITE WAS RED AND RAISED FOR 3-4 DAYS; BAD HEADACHE; NAUSEA; INJECTION SITE WAS RED AND RAISED FOR 3-4 DAYS; WHOLE BODY ITCHED; INJECTION SITE WAS ITCHY; BIG HARD LUMP AT INJECTION SITE LIKE A MOSQUITO HAD BITTEN; This spontaneous report received from a patient concerned a 46 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 01-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-JUL-2021, the subject experienced big hard lump at injection site like a mosquito had bitten. On 02-JUL-2021, the subject experienced injection site was red and raised for 3-4 days. On 02-JUL-2021, the subject experienced whole body itched. On 02-JUL-2021, the subject experienced injection site was itchy. On 02-JUL-2021, the subject experienced injection site was red and raised for 3-4 days. On 02-JUL-2021, the subject experienced bad headache. On 02-JUL-2021, the subject experienced nausea. On 04-JUL-2021, the subject experienced tingling in right arm and fingertips. On 04-JUL-2021, the subject experienced tingling in left arm and fingers. On 04-JUL-2021, the subject experienced dry mouth. On 04-JUL-2021, the subject experienced could not eat much. On 04-JUL-2021, the subject experienced felt like a truck hit. On 05-JUL-2021, the subject experienced numbness in right hand and fingertips. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site was red and raised for 3-4 days, injection site was red and raised for 3-4 days, bad headache, and nausea on 04-JUL-2021, and tingling in left arm and fingers on 07-JUL-2021, was recovering from whole body itched, and injection site was itchy, had not recovered from big hard lump at injection site like a mosquito had bitten, numbness in right hand and fingertips, and tingling in right arm and fingertips, and the outcome of dry mouth, could not eat much and felt like a truck hit was not reported. This report was non-serious.
Hot then cold; She says she couldn't stand; Really fatigued day after 1st dose; maybe with fever after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE FLUCTUATION (Hot then cold), MUSCULAR WEAKNESS (She says she couldn't stand), FATIGUE (Really fatigued day after 1st dose) and PYREXIA (maybe with fever after 1st dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a21a) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020. Concurrent medical conditions included Hypertension. Concomitant products included METOPROLOL, CLONIDINE, LOSARTAN, MONTELUKAST, SALBUTAMOL SULFATE (VENTOLIN ACCUHALER) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced BODY TEMPERATURE FLUCTUATION (Hot then cold), MUSCULAR WEAKNESS (She says she couldn't stand), FATIGUE (Really fatigued day after 1st dose) and PYREXIA (maybe with fever after 1st dose). At the time of the report, BODY TEMPERATURE FLUCTUATION (Hot then cold), MUSCULAR WEAKNESS (She says she couldn't stand), FATIGUE (Really fatigued day after 1st dose) and PYREXIA (maybe with fever after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 59-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Nov2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 59 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Biaxin, reaction(s): "known allergies: biaxin"; Ceftin, reaction(s): "known allergies: ceftin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Dec2022) Positive, notes: COVID 19 Treatment; (23Dec2022) Negative, notes: tested negative 23Dec2022; (26Dec2022) Positive, notes: tested positive again 26Dec2022. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient had rebound coughing and runny nose which began 24Dec2022 tested negative 23Dec2022, tested positive again 26Dec2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information in the case, an association between the reported events DRUG INEFFECTIVE , COVID 19  and The suspected drug cannot be ruled out.
PATIENT RECEIVED VACCINE 9 DAYS AGO AND NOW HAS REDNESS WARMTH FIRMNESS AND DISCOMFORT @ SITE.
COVID Breakthrough Case  Pfizer Dose 1 9/11/21 (lot not listed in database) COVID Positive 9/27/21 (approximately, pt reported)  9/30/21: The patient presents with fever.  The course/duration of symptoms is constant and worsening. Risk factors consist of none.  Prior episodes: none. Therapy today: none.  The patient states that she has been diagnosed with COVID a few days ago and has received the vaccine and but started to feel ill.  Patient presents here headache, fever nausea vomiting malaise and generalized fatigue.  Patient states she can not concentrate can not think can not eat or drink and renal failure her life.  10/2/21: 63 yo f with no major cardiac or pulmonic pathology who has had COVID symptoms for the last 5 days. Headache, some nausea, vomiting, cough, breathing difficulty.  Lightheadedness, dizziness and weakness.  She was seen in the ER.  Non hypoxic.  She had bilateral pneumonia she was given Rocephin, azithromycin.  She has done well pulse ox is now 95% on last check on room air she has never been hypoxic.  She still has fevers.  But she is eating and drinking well and able to ambulate without significant difficulty.  She, is not a can according to hospitals at Genesis East for band line available as an inpatient, or numbness severe or Decadron as an inpatient without hypoxia.  She received some Levaquin this morning. She tolerated that well again she is eating and drinking ambulating.  And she wants to go home.  So I am going to discharge her home.  So diagnosis is COVID pneumonia, without hypoxia on Levaquin for possible community-acquired pneumonia.  As inpatient she is not, she is hypoxic qualified according to Genesis East for other medicines but as an outpatient she might be a candidate for MI Nevada. Will have to leave that up to her primary care provider but her body mass index is less than 35 she is less than 65 years old she has no primary pulmonic or cardiac disease and she is not immunocompromised so I cannot prescribe that for at this time.  But she wants to go home and she tolerated p.o. antibiotic at think she is fine to go home.
Pt received 1st HPV June 23, 2017 - had slight prickly itchy rash on deltoid lasted a few days. Pt received HPV #2 and TRUMENBA #1 8/18/17. On 8/22/17 pt had knee pains and achy. On 8/23/17 pt was moving into college (freshman) and had low grade fevers/chills. Took 400 mg Ibuprofen.
Has been complaining of severe pain since the day of the immunization in his right arm--he is a weight lifter, and has been unable to lift weights--states when he rotates his arm hears a  crackling sound--no unusual redness or swelling noted by mom--referred to medical provider for an assessment of the problem.
Numbness/weird feeling along side of body: same side vaccine was given on (left). Resolved in about 15 min. and pt. left pharmacy.
Fully vaccinated as of 1/11/21 and tested positive for COVID-19 on 8/9/21. Symptoms of fever, body aches, and fatigue started on 8/6/21. Patient is not immunocompromised.
1wk p/vax fever, rash resolved;12OCT98 rash & fever MD visit 12OCT98 petechia;CBC done-WBC 7.5, platelet 5,000;dx ITP secondary MMR;referred to hlth dept;CBC repeat 48hr 15OCT98;
3RD DOSE OF COVID VACCINE, PFIZER GIVEN 12/30/21, LOT #FD0809 - LW pt had a positive COVID test on 7/19/22 at the Medical Center. Dc'd to another location where she passed away on 7/31/22;  Number of days in the hospital and plan of care unknown from medical records.
Felt dizzy and lightheaded the morning after injection which worsened for few hours then began to less in intensity. Symptoms have gradually reduced since 9/28/16 and currently feels symptoms very slightly.
Soreness; This spontaneous case was reported by a physician and describes the occurrence of   in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history not reported). Concomitant products included WARFARIN SODIUM (COUMADIN), VITAMIN D NOS, EZETIMIBE (ZETIA) and POLYCARBOPHIL CALCIUM (FIBER) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; CODEINE at an unspecified dose and frequency and FENTANYL at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator
break out in welts; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (break out in welts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (break out in welts). At the time of the report, URTICARIA (break out in welts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.
6 days after vaccine dose #1, itchy and redness after injection. Red area on arm at injection site became largest on day 8 and raised 3x3 inches.
Hives; This is a spontaneous report from a contactable healthcare professional (patient). A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL0142; Expiration date was not reported) on 30Dec2020 (09:30) at a single dose on the left arm, with route of administration unspecified, for COVID-19 immunization at the hospital. Medical history included asthma, gastroesophageal reflux disease (GERD) and allergy to sulfa drugs. Concomitant medication included omeprazole. On 06Jan2021 (20:00), the patient had hives. The hives was further reported to have occurred in two instances: first was 14 days after receiving the vaccine, and the second was 17 days after vaccination (pending clarification on event onset date). The patient did not receive any treatment for the reported event. The outcome of the event, hives, was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to the vaccination, and was not tested post-vaccination.
A lot of Hair loss. Possiblessings telogen effluvium from GARDASIL 9 vaccine.
Patient was given a Moderna shot but did not qualify by age to be given the Moderna vaccine.  The patient was monitored after the shot for any adverse reactions and did not display any.
Hep B given before working at hospital I have look for records at hospital but unable to recovey. I have Heb B since I was given the live virus. On a routine visit to OB/Gyn Doctor 3/19 found out I have been exposed to virus but never had any symptoms. Or been exposed I feel I was given a live virus of the shot because my antibodies are normal
Swelling, warmth and redness and firm tissue at the PNEUMOVAX 23 injection site 6 hrs after injection. Right arm-started on KEFLEX 500mg BID. Cool compresses to site. Elevation.
low grade fever; fatigue; Injection site sore; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: er8732) via an unspecified route of administration in the left arm on 28Mar2021 at 19:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no allergies to medications, food, or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6205) via an unspecified route of administration in the left arm on 07Mar2021 at 19:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not undergo a COVID-19 test. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Following day of vaccination on 29Mar2021 at 00:00, the patient experienced low grade fever, fatigue and injection site sore. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events low grade fever, fatigue and injection site sore. The clinical outcomes of the events low grade fever, fatigue and injection site sore were recovering at the time of reporting.  No follow-up attempts are possible. No further information is expected.
Tested positive for Covid; A spontaneous report  was received from a healthcare professional (pharmacist) concerning a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tested positive for Covid/ SARS-CoV-2 test positive.  The patient's medical history included Urinary tract infection, in the hospital, patient got plasma and antibiotics for Urinary tract infection. Concomitant medications reported were Metformin for drug use for unknown indication.  On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 29 Jan 2021, the patient experienced the event(s) tested positive for Covid.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event, tested positive for Covid was unknown.
First shot was on 17Mar2021. He didn't experience the swelling so much; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Mar2021 (Lot number: ER2613) at the age of 64 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetic", start date: 1994 (ongoing). There were no concomitant medications. The following information was reported: SWELLING (non-serious) with onset 2021, outcome "unknown", described as "First shot was on 17Mar2021. He didn't experience the swelling so much".  Additional information: First shot was on 17Mar2021. He didn't experience the swelling so much. Lot number: ER2613.  No follow-up attempts are possible. No further information is expected.
Itchiness and hives all over my body 2 weeks after the injection. The same occurred with my first booster (3rd dose - Moderna 064H21A)
12 hrs post vax devel 105 temp (2 days); given APAP;